Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.
Although most advanced prostate cancer patients respond to androgen-deprivation therapy (ADT), the efficacy is widely variable. We investigated whether the host genetic variations in sex hormone pathway genes are associated with the efficacy of ADT. A cohort of 645 patients with advanced prostate ca...
Main Authors: | Chia-Cheng Yu, Shu-Pin Huang, Yung-Chin Lee, Chao-Yuan Huang, Chia-Chu Liu, Tzyh-Chyuan Hour, Chun-Nung Huang, Bang-Jau You, Ta-Yuan Chang, Chun-Hsiung Huang, Bo-Ying Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3554749?pdf=render |
Similar Items
-
Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.
by: Shu-Pin Huang, et al.
Published: (2012-01-01) -
Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
by: Ling-Chun Huang, et al.
Published: (2022-08-01) -
Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease
by: Ping-Song Chou, et al.
Published: (2022-01-01) -
<i>NRG1</i> Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
by: Shu-Pin Huang, et al.
Published: (2021-05-01) -
Androgen deprivation therapy and the risk of subsequent keratitis
by: Dai-Wei Liu, et al.
Published: (2021-01-01)